Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children

Journal of Infectious Diseases

Volumn 164, Issue 2, 1991, Pages 271-276

  Wright, Peter F ^a   King, James ^b   Araki, Kazuko ^c   Kondo, Yasuo ^c   Thompson, Juliette ^d   Tollefson, Sharon J ^d   Kobayashi, Masaaki ^d   Kapikian, Albert Z ^d  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c TEIKYO UNIVERSITY   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VIRUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNITY; INFANT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ROTAVIRUS; SEROTYPE; UNITED STATES; VACCINATION; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANIMAL; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HEMAGGLUTINATION INHIBITION TESTS; HUMAN; INFANT; MACACA MULATTA; NEUTRALIZATION TESTS; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0025826711     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/164.2.271     Document Type: Article

References (17)

1. Flores J, Nakagomi O, Nakagomi T, et al. The role of rotaviruses in pediatric diarrhea. Pediatr Infect Dis J 1986;5(suppl):S53-62.
2. Institute of Medicine. Appendix D-13. The prospects for immunizing against rotavirus. In: New vaccine development. Establishing priorities. Vol II. Diseases of importance in developing countries. Washington, DC: National Academy Press, 1986:308-18.
3. Kapikian AZ, Flores J, Hoshino Y, et al. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis 1986;153:815-22.
4. Halsey NA, Anderson EL, Sears SD, et al. Human-rhesus rotavirus vaccines: safety and immunogenicity in adults, infants, and children. J Infect Dis 1988;158:1261-7.
5. Wright PF, Tajima T, Thompson J, Kokubun K, Kapikian AZ, Karzon DT. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. Pediatrics 1987;80:473-80.
6. Tajima T, Thompson J, Wright PF, et al. Evaluation of a reassortant rhesus rotavirus vaccine in young children. Vaccine 1990;8:70-4.
7. Kalica AR, Garon CF, Wyatt RG, et al. Differentiation of human and calf reovirus-like agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA. Virology 1976;74:86-92.
8. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Monotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis 1990;161:667-79.
9. Chiba S, Yokoyama T, Nakata S, et al. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986;2:110-5.
10. Christy C, Madore HP, Pichichero ME, et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 1988;7:645-50.
11. Flores J, Perez-Schael I, Gonzalez M, et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987;1:882-4.
12. Offit PA, Blavat GE, Greenberg HB, Clark HF. Molecular basis of rotavirus virulence: role of gene segment 4. J Virol 1986;57:46-9.
13. Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J Virol 1988;62:744-8.
14. Offit PA, Clark HF. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol 1985;54:58-64.
15. Offit PA, Dudzik KI. Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J Virol 1988;62:127-31.
16. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 1986;153:832-9.
17. Perez-Schael I, Blanco M, Vilar M, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28:553-8.